First human trial of potential antibody treatment for Covid-19 begins
Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat Covid-19.
Eli Lilly and Company said Monday it has started the first human trial of an antibody therapy designed to treat Covid-19.